Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes Reply

Wang, F; Zhao, Q; Xu, RH

Xu, RH (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, 651 Dong Feng Rd E, Guangzhou 510060, Peoples R China.

JAMA ONCOLOGY, 2020; 6 (4): 590

打开APP